Table 2.
Objectives suggested and scored by participants
| Objective | Cumulative score |
|---|---|
| Separate assessment of leptomeningeal and parenchymal CAA | 28 |
| Clear indication in assessment summary of regions affected | 28 |
| Record ‘secondary’ pathologies such as fibrinoid necrosis | 26 |
| Obtain an overall score of CAA severity | 26 |
| Categorise according to type of affected vessel in each region (i.e. arterioles and capillaries) | 26 |
| Allow for grading of CAA in biopsy as well as autopsy material | 22 |
| Allow for integration of clinical and radiological information in the assessment | 18 |
| Score severity according to maximum severity observed in any region | 17 |
| Take APOE genotype into account | 13 |